Status:
COMPLETED
Application of Megavoltage Imaging to Reduce Artifact After Seed Implants
Lead Sponsor:
William St Clair
Conditions:
Prostate Cancer
Eligibility:
MALE
50-80 years
Brief Summary
This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cance...
Eligibility Criteria
Inclusion
- Male 50-80 years of age Eligible for interstitial brachytherapy implants
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01810627
Start Date
September 1 2013
End Date
April 1 2016
Last Update
September 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Markey Cancer Center
Lexington, Kentucky, United States, 40536